Federal government to fund hotline promoting abortion pill reversal
H.R. 796 — Second Chance for Moms Act · Filed by Mary Miller (R-IL) · 13 cosponsors · Introduced Jan 28, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires mifepristone (the abortion pill) to carry a warning label stating that its effects can allegedly be counteracted by natural progesterone, and directs the federal government to establish and fund a 24/7 hotline to refer women seeking to reverse mifepristone's effects to providers offering 'abortion pill reversal' services. The bill frames this as giving women a 'second chance' to continue pregnancy after taking the drug.
Why we flagged it
The bill's operative mechanism is not to restrict mifepristone access but to mandate a warning label promoting a specific medical countermeasure and to establish federal funding for a referral hotline directing women to providers of that service. This is functionally a government endorsement and subsidy of abortion-pill-reversal services.
What the text implies
- The warning label cites 'medical evidence' and the American Society for Reproductive Medicine regarding progesterone safety, but the bill does not require the label to disclose that major medical organizations (ACOG, ASRM itself in broader guidance) do not endorse mifepristone reversal as a standard-of-care intervention, creating a one-sided medical narrative.
- The hotline is restricted to referrals to 'APR providers only' — a narrow carve-out that excludes general OB/GYN practices, family medicine, or other providers, effectively creating a government-funded referral monopoly for a specific service sector.
- Federal funding for the hotline creates an ongoing appropriation obligation; the bill does not specify a budget cap, meaning the cost to taxpayers is open-ended.
- The 6-month implementation window for the label is tight; manufacturers will need to reformulate labeling quickly, creating compliance costs that may be passed to consumers or absorbed by the pharmaceutical supply chain.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill creates a concrete public cost: federal funding for a hotline promoting a medical intervention (progesterone reversal) whose efficacy remains disputed in mainstream medical literature, and it mandates a warning label containing a medical claim that does not reflect consensus scientific evidence. However, the bill does not restrict access to mifepristone itself, and providing information (even contested information) to women is not inherently a harm — the tension between informed choice
Who stands to gain
- abortion pill reversal service providers
- clinics offering mifepristone-reversal protocols
Named in the bill
FDA, mifepristone, American Society for Reproductive Medicine, Department of Health and Human Services, Title X of the Public Health Service Act, Federal Food, Drug, and Cosmetic Act
Where it stands
13 cosponsors: 13 Republicans.
- Jan 28, 2025 — Introduced · Congress.gov: “Introduced in House”
- Jan 28, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,621 characters) on Aug 18, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Federal government to fund hotline promoting abortion pill reversal” QuorumCivic. https://share.quorumcivic.app/bill/119/hr796 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.